SlideShare a Scribd company logo
Division of National Malaria Programme – Komesha Malaria, Okoa Maisha
Ministry of Health
Module 2: Learning Unit 2
Management of Severe Malaria
Training of Malaria Case Management
Master trainers
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Learning Unit 2:
Management of Severe
Malaria
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Learning objectives
By the end of the learning unit, the participants will be
able to:
1. Identify signs and symptoms of Severe malaria
2. Diagnose Severe malaria
3. Describe pre-referral management of severe malaria
4. Describe management of severe malaria
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Signs and symptoms of Severe Malaria
Severe malaria is a life threatening condition defined as Peripheral parasitaemia in the
presence of the following clinical or laboratory features
• Prostration,
• altered consciousness,
• respiratory distress,
• multiple generalized convulsions,
• severe anaemia (Hb<5g/dl),
• hypoglycaemia (<2.2mmol/l),
• jaundice
• NB- features may occur singly or in combination,
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
What are the signs and symptoms of
severe malaria
(Brainstorm)
GROUP
BRAINSTORMING
What are the signs
& symptoms of
severe malaria?
14
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Conjugate deviation of the eyes to the left or upwards
6
National Malaria Control Programme – Komesha Malaria, Okoa Maisha 7
National Malaria Control Programme – Komesha Malaria, Okoa Maisha 8
National Malaria Control Programme – Komesha Malaria, Okoa Maisha 9
National Malaria Control Programme – Komesha Malaria, Okoa Maisha 10
National Malaria Control Programme – Komesha Malaria, Okoa Maisha 11
11
National Malaria Control Programme – Komesha Malaria, Okoa Maisha 12
12
National Malaria Control Programme – Komesha Malaria, Okoa Maisha 13
13
National Malaria Control Programme – Komesha Malaria, Okoa Maisha 14
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Diagnosis of Severe malaria
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Role of laboratory diagnosis in severe
malaria
• Parasitological confirmation is recommended
• Presumptive treatment should be started immediately
while waiting for parasitological confirmation
• Antimalarial treatment should not be withheld if
parasitological diagnosis is not possible or delayed
• Other investigations to determine severity and prognosis
should be undertaken where feasible
• (HB, Blood sugar, Urea and electrolyte)
• Positive slides do not rule out other causes of severe
disease
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Clinical Manifestations of Severe Malaria
• Cerebral Malaria
• Severe Anaemia
• Hypoglycaemia
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Assessment Tasks For Cerebral malaria (1)
i. Clinical assessment
• Assess level of consciousness using coma score.
• Determine the presence of severe anaemia
• Determine presence of respiratory distress
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Assessment Tasks For Cerebral malaria cont’d
• Determine hydration status
• Assess for renal insufficiency
• Assess for evidence of Disseminated Intravascular Coagulopathy (DIC)
• Assess for stiff neck and do lumbar puncture
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Assessment Tasks For Cerebral malaria cont’d
ii. Laboratory Tests
• In children with altered consciousness, start treatment for both malaria and
meningitis until lumbar puncture results exclude meningitis
• Do blood glucose to rule out hypoglycemia
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Assessment Tasks For Severe Anaemia (1)
i. Clinical assessment
• Examine for pallor on the palms and conjunctiva
• Determine presence of respiratory distress
• Assess for shock
• Assess for evidence of Disseminated Intravascular Coagulopathy
• Assess for evidence of cardiac failure
• Pulmonary oedema
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Assessment Tasks For Severe Anaemia (2)
ii. Laboratory test.
• Determine haemoglobin levels, blood group and cross match where applicable
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Assessment Tasks For Hypoglycaemia
i Clinical assessment
• Assess the level of consciousness
ii Laboratory test
• Determine the blood glucose level
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Part 2
Pre-referral management
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Pre-referral treatment (1)
• Treatment for suspected severe malaria provided at the
peripheral facility where IV infusion cannot be given as
patient waits for referral
• Initiate treatment with IM artesunate
• If patient has altered consciousness, administer
antibiotic for meningitis (e.g. Ceftriaxone)
Pre-referral Treatment
• Treatment for suspected severe malaria
provided at the peripheral facility where IV
infusion cannot be given as patient waits for
referral
• If patient has altered consciousness, administer
antibiotic for meningitis (e.g. Ceftriaxone)
• Initiate treatment
with IM artesunate
44
Pre-referral Treatment cont’d
Transport child lying on the side
Health worker should accompany patient
Investigate mode of transporting patient
All attempts should be made to refer patients
• Give clear referral note with clinical
picture and medications given and doses
• If investigations were done, send results
or slides along with patient
45
ARTESUNATE PRODUCT DESCRIPTION
• Artesunate dispensed as
Artesunic powder
• Dissolved in sodium
bircarbonate (5%) to form
sodium artesunate
• Solution then dissolved in
5mls of normal saline or
5% dextrose
• USE OF WATER FOR INJECTION
NOT RECOMMEDED
Artesunate
powder
Bicarbonate
ampoule
Saline
Solution
+
47
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
• Administer treatment in the following order of
preference depending on availability:
IM artesunate
Rectal Artesunate (suppositories)
IM Quinine
IM Artemether
ARTESUNATE PRODUCT DESCRIPTION
• Artesunate dispensed as
Artesunic powder
• Dissolved in sodium
bircarbonate (5%) to form
sodium artesunate
• Solution then dissolved in
5mls of normal saline or
5% dextrose
• USE OF WATER FOR INJECTION
NOT RECOMMEDED
Artesunate
powder
Bicarbonate
ampoule
Saline
Solution
+
47
Pre-Referral dosage of IM
artesunate
• Administer 3.0mg/kg for children < 20kg ,
then refer
• Administer 2.4mg/kg for children > 20kg
and adults, then refer
48
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Rectal Artesunate
• Rectal artesunate is presented as suppositories
• Administer a single dose
• If expelled before 30 mins, insert a second one
• For young children hold the buttocks for 10 mins to
retain the suppository
• For patients above 6 yrs, Rectal artesunate is not
recommended
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Dose of IM quinine
• Quinine must be diluted to a maximum of
• 50mg/ml in children
• 100mg/ml in adults before IM administration
• Loading dose for IM quinine is 20mg/kg in ALL age groups ( to a maximum of
1200mg)
• A maximum of 3ml to be injected at one site
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Disadvantages of IM quinine
• Risk of sterile abscesses
• Relatively poor absorption of quinine (less drug available) compared to IV or
oral quinine – the illness may worsen
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
IM Artemether
• IM artemether is fat soluble
• It is provided in dilution form
• Administer as a stat dose
• Administer IM 3.2mg/kg/body wt
• Refer patient after administration
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Part 3
In patient management of severe malaria
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
IM Artemether
• IM artemether is fat soluble
• It is provided in dilution form
• Administer as a start dose
• Administer IM 3.2mg/kg/body wt
• Refer patient after administration
STEP 1. WEIGH
THE PATIENT
STEP 2. CHECK
VIALS NEEDED NOTE:
• Each vial require separate reconstitution,
dilution and administration
• Reconstitute immediately before use 54
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
STEP 3: RECONSTITUTE
A
B
C
D
STEP 4: DILUTION
C
B
A
D
VOLUME FOR DILUTION IV IM
Bicarbonate Solution Volume 1ml 1ml
Saline Solution 5ml 2ml
Total Volume 6ml 3ml
Artesunate 60mg solution
concentration
10mg/ml 20mg/ml
55
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
STEP 5. CALCULATE DOSE
Less than 20 kg(IV) Less than 20kg (IM)
More than 20 kg(IV) More than 20kg (IM)
56
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Part 3
Inpatient management of Severe Malaria
STEP 1. WEIGH
THE PATIENT
STEP 2. CHECK
VIALS NEEDED NOTE:
• Each vial require separate reconstitution,
dilution and administration
• Reconstitute immediately before use 54
STEP 3: RECONSTITUTE
A
B
C
D
STEP 4: DILUTION
C
B
A
D
VOLUME FOR DILUTION IV IM
Bicarbonate Solution Volume 1ml 1ml
Saline Solution 5ml 2ml
Total Volume 6ml 3ml
Artesunate 60mg solution
concentration
10mg/ml 20mg/ml
55
STEP 5. CALCULATE DOSE
Less than 20 kg(IV) Less than 20kg (IM)
More than 20 kg(IV) More than 20kg (IM)
56
6. ADMINISTER
• 3 parenteral doses over 24 hrs
• Continue parenteral treatment (1 dose
daily) until patient can take oral medication
(Max 7 days)
• Mandatory full 3-day course of ACT as soon
as patient can take oral medication
– 1st dose of ACT btwn 8 & 12 hrs after last
injection
• Evaluate patients progress continuously
7. DOSING SCHEDULE
57
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Quinine administration in children
• Loading dose of 20mg/kg in 15ml/kg of 5% dextrose or normal saline to run
over 4 hours
• Omit loading dose if any quinine has been given in the previous 24 hours
• 8 hours from commencement of initial dose, give 10mg/kg quinine in 10ml/kg
of 5% dextrose or normal saline to run over 4 hours
• Repeat 10mg/kg infusion every 8 hours until the patient is able to sit up and
take oral medication
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Quinine administration in adults
• Loading dose of 20mg/kg (maximum of 1200mg)in 5% dextrose or normal
saline to run over 4 hours
• Omit loading dose if any quinine has been given in the previous 24 hours
• Maintain with 10mg/kg (maximum of 600mg) infusion 8 hourly until the
patient is able to take oral medication
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Follow on treatment after IV quinine
• Once all patients are able to take oral medication:
• Give a full course of artemether-lumefantrine
OR
• Continue oral quinine at 10mg/kg (max 600mg) 8 hourly for a total of 7 days of
treatment
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Supportive treatment
• Hypoglycaemia – IV or oral glucose (10% glucose 5
ml/kg)
• Convulsions
• diazepam 0.3mg/kg IV or 0.5 mg/kg rectally
• Phenytoin or phenobarbitone
• Severe anaemia – transfuse
• Fluid and electrolyte balance
• Fever and nursing care
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Frequent questions
1. Would you give Artesunate / IV Quinine to a child with severe malaria and
Hb of 3g/dl?
2. Would you give fluid to a child with Hb of 3g/dl before giving a blood
transfusion?
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Answers
1. Yes, Artesunate or quinine must be given as soon as possible while waiting
for blood transfusion.
2. Yes, children with severe malaria and severe anaemia can be given fluids
while waiting for blood transfusion.
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case studies
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case study 1
• A 2-year-old girl from an area with stable malaria develops fever and soon
has a brief convulsion. The family lives in a remote community away from
the city. Initially the mother gave the child a teaspoonful of herbal
concoction. Later, on the evening of the same day, the child's speech
became less comprehensible and shortly afterwards she was no longer
responding to any call. It took the mother 4 hours to get to the nearest
hospital and the child remained unconscious until they got there. In
addition to the loss of consciousness, she was found on examination to be
severely pale with a temperature of 38.5°C.
• What key information is provided in this history?
• What signs of severe disease can you identify?
• How should this child’s illness be classified
• What urgent treatment would you give
• List 4 important laboratory tests to be done.
• What specific treatment would you give this child?
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case history 2
• The place: a rural clinic in a hyper endemic P. falciparum area.
Various antimalarial drugs are available, but intravenous infusions
cannot be given.
• A child aged 20 months became feverish two days ago and has
vomited several times today. One hour ago the child had a
convulsion, described by the mother as a repetitive twitching of
the limbs and mouth, followed by unresponsiveness for a few
minutes. The child is now febrile (39°C), conscious, and withdraws
promptly from any painful stimulus. A thick blood film shows P.
falciparum rings “860/200”WBC. The child repeatedly vomits any
antimalarial drug given by mouth.
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case study 2 cont’d
• Does the child have cerebral malaria? Why?
• What should you do about the convulsions?
• What treatment will you give? State dose & route of
administration.
On the second day of treatment, the child was brought back to the
clinic. There was little change; he was still febrile and the
parasitaemia was similar to the previous day.
• Does this suggest that the child has drug resistant malaria?
The child went on to complete a full course of AL. By the 3rd day, he
was well and aparasitaemic.
At the end of 7 days a further blood test showed gametocytes.
• What should be done about the gametocytes present in the blood
after treatment?
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
…Case study 3 cont’d
i. What are the differential diagnoses?
ii.Was the patient right to think he was immune to malaria?
iii.The thick blood film shows P falciparum 3900/200 WBC and
the thin blood film shows that 26% of the red cells are
parasitized. What else would you look for in the thin blood
film?
iv.What else would you do to investigate the bleeding tendency?
v.What treatment is needed for the bleeding?
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case study 3
• 4. A four-year-old girl is brought to the outpatient department of your hospital by her mother, late in the
evening. The child was well until yesterday morning (36 hours ago), when she began to have fever. Yesterday
she took meals but seemed restless; today she has refused food, and only drank a little. The mother says the
child had a “fit” this morning; she regained consciousness immediately. For the past few hours the child has
been increasingly drowsy, and for the last hour has been unconscious.
• On examination the child is well nourished, unconscious and not dehydrated. The axillary temperature is
40.2°C; pulse 120 beats/min, regular; blood pressure 90/70 mmHg. No neck stiffness. Some yellowish sticky
fluid is seen filling the external part of the left ear. There was no rash.
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case study 3
i. What essential laboratory tests will you perform to guide your
management of the patient?
ii. Why does the blood glucose test have priority in this case?
iii.Should you wait for the blood glucose test if it will take more than 2 hours?
iv.So what should you do?
In this child, a stix test on finger-prick capillary blood revealed a glucose level
of 1.0 mmol/L (18 mg/dl). 50% dextrose was given intravenously but the
child remained unconscious. What does this suggest?
• The child has P falciparum parasitaemia 465/200 WBCs with
hypoglycaemia.
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case study 3 cont’d
v. Does this exclude a diagnosis of meningitis?
vi. If stiff neck is absent is it necessary to do a lumbar puncture?
vii. Does clear & colourless cerebrospinal fluid exclude
meningitis?
viii. what antimalarial drug will you give the patient? Give the
dose and route.
ix. If haemoglobin is 6.3.mg/dL. What will you do?
x. At what point would you give a blood transfusion?
xi. If blood transfusion is necessary, how would you give the
blood?
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
xii. What clinical observations would you maintain during
management?
xiii. What laboratory tests would you repeat, and frequency?
xiv. What should be looked for after the child has recovered?
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case study 5
• The place: A country where P. falciparum malaria is transmitted in forested
areas but not in the main cities.
• A woman aged 25 years is brought to the outpatient department of the
central hospital in the capital. She is a local resident, the wife of a business
executive, and is in the seventh month of her pregnancy.
• The patient became ill five days ago, with chills, sweating and headache. An
antibiotic was prescribed and her condition seemed to improve, but
yesterday she developed rigors and persistent vomiting. A blood film at the
local clinic revealed malaria parasites, and oral quinine (600 mg every 8
hours) was prescribed. She took two doses.
• Today she has been referred to your hospital because of confusion.
Examination reveals a semiconscious woman who is unable to talk. She
withdraws her hand from a painful stimulus but cannot localize a stimulus
applied to the sternum or forehead. There is no neck stiffness, jaundice,
pallor or rash. Axillary temperature is 39°C, pulse 90 beats/min, blood
pressure 110/70 mmHg. The uterine fundus is palpable (26 - 28 weeks) and
the foetal heart can be heard.
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
…Case history 5
i) What other questions would you ask the patient’s relatives?
ii) What tests are urgently required?
ii) If the blood glucose is 1.2 mmol/L, what treatment will you give?
iii) If the blood film shows P falciparum 465/200 WBCs, and the cerebrospinal fluid is normal except for low
glucose, what antimalarial drug would you administer and by what route?
iv) Would you prefer an alternative to quinine because of the pregnancy?
v) Would you give a loading dose of quinine?
vi) What nursing procedures are important during this treatment?
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Case history 5 cont’d
i. What other questions would you ask the patient’s relatives?
ii. What important tests should be done?.
• a)
• b).
• c).
• d).
iii.If the blood glucose is 1.2 mmol/L, what treatment will you give?
iv.If the blood film shows P. falciparum 465/200 WBCs, and the cerebrospinal
fluid is normal except for low glucose, what antimalarial drug would you
administer and by what route?
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
v. Would you prefer an alternative to quinine because of the
pregnancy?
vi. Would you give a loading dose of quinine?
vii. What nursing procedures are important during this
treatment?
After 6 hours, the patient becomes increasingly restless. The
respiratory rate increased to 40/minute. The blood glucose
level is normal. Under these conditions, what special
observations would you make?
• a)
• b)
National Malaria Control Programme – Komesha Malaria, Okoa Maisha
Thank you
55
Division of National Malaria Programme – Komesha Malaria, Okoa Maisha
Malaria Free KENYA
Elimination
SMEOR
Case Mgmt SBC
Vector Control
MIP
Prog
Mgmt
56

More Related Content

Similar to Nsaids

Malaria
MalariaMalaria
F imnci management of sick young infant
F imnci  management of sick young infantF imnci  management of sick young infant
F imnci management of sick young infant
sudhashivakumar
 
Pediatric malaria.pptx
Pediatric malaria.pptxPediatric malaria.pptx
Pediatric malaria.pptx
AliDahir4
 
diagnosis and treatment of malaria
diagnosis and treatment of malariadiagnosis and treatment of malaria
diagnosis and treatment of malaria
Krithiga Sivakumar
 
Sovran rai
Sovran raiSovran rai
Sovran rai
Sovranrai1
 
Toxicology symposium
Toxicology symposiumToxicology symposium
Toxicology symposium
nswhems
 
MALARIA.pptx
MALARIA.pptxMALARIA.pptx
MALARIA.pptx
Ankit Gajjar
 
Severe malaria
Severe malariaSevere malaria
Severe malaria
Nirav Valand
 
Uncomplicated Malaria 17_03_2021 JC edits.pptx
Uncomplicated Malaria 17_03_2021 JC edits.pptxUncomplicated Malaria 17_03_2021 JC edits.pptx
Uncomplicated Malaria 17_03_2021 JC edits.pptx
DennisSarfo3
 
Malaria 17_03_2021 JC edits.pptx
Malaria 17_03_2021 JC edits.pptxMalaria 17_03_2021 JC edits.pptx
Malaria 17_03_2021 JC edits.pptx
kojoBUSIA1
 
Seizure ppt pres- Sandra amd Johny(1).pptx
Seizure ppt pres- Sandra amd Johny(1).pptxSeizure ppt pres- Sandra amd Johny(1).pptx
Seizure ppt pres- Sandra amd Johny(1).pptx
ssusera4ec8c
 
Guideline for management of TBI by Dr.sagor
Guideline for management of TBI by Dr.sagorGuideline for management of TBI by Dr.sagor
Guideline for management of TBI by Dr.sagor
Chittagong Medical College Hospital
 
Acute Gasteoenteritis in Children and Adults.pptx
Acute Gasteoenteritis in Children and Adults.pptxAcute Gasteoenteritis in Children and Adults.pptx
Acute Gasteoenteritis in Children and Adults.pptx
LeannElizaGutierrez
 
nutrition.pptx
nutrition.pptxnutrition.pptx
nutrition.pptx
MesfinShifara
 
malaria guidelines - a case of tropical fever ppt.
malaria  guidelines - a case of tropical fever ppt.malaria  guidelines - a case of tropical fever ppt.
malaria guidelines - a case of tropical fever ppt.
ssuser4326621
 
Malaria
MalariaMalaria
MALARIA
MALARIAMALARIA
Management of severe malaria
Management of severe malariaManagement of severe malaria
Management of severe malaria
University of Gondar
 
Presentation TS neocone fluid and electrolyte dr hemant - Copy - Copy.pptx
Presentation TS neocone fluid and electrolyte dr hemant - Copy - Copy.pptxPresentation TS neocone fluid and electrolyte dr hemant - Copy - Copy.pptx
Presentation TS neocone fluid and electrolyte dr hemant - Copy - Copy.pptx
ssuser00be96
 
Isonized overdose
Isonized overdose Isonized overdose
Isonized overdose
Ministry of health
 

Similar to Nsaids (20)

Malaria
MalariaMalaria
Malaria
 
F imnci management of sick young infant
F imnci  management of sick young infantF imnci  management of sick young infant
F imnci management of sick young infant
 
Pediatric malaria.pptx
Pediatric malaria.pptxPediatric malaria.pptx
Pediatric malaria.pptx
 
diagnosis and treatment of malaria
diagnosis and treatment of malariadiagnosis and treatment of malaria
diagnosis and treatment of malaria
 
Sovran rai
Sovran raiSovran rai
Sovran rai
 
Toxicology symposium
Toxicology symposiumToxicology symposium
Toxicology symposium
 
MALARIA.pptx
MALARIA.pptxMALARIA.pptx
MALARIA.pptx
 
Severe malaria
Severe malariaSevere malaria
Severe malaria
 
Uncomplicated Malaria 17_03_2021 JC edits.pptx
Uncomplicated Malaria 17_03_2021 JC edits.pptxUncomplicated Malaria 17_03_2021 JC edits.pptx
Uncomplicated Malaria 17_03_2021 JC edits.pptx
 
Malaria 17_03_2021 JC edits.pptx
Malaria 17_03_2021 JC edits.pptxMalaria 17_03_2021 JC edits.pptx
Malaria 17_03_2021 JC edits.pptx
 
Seizure ppt pres- Sandra amd Johny(1).pptx
Seizure ppt pres- Sandra amd Johny(1).pptxSeizure ppt pres- Sandra amd Johny(1).pptx
Seizure ppt pres- Sandra amd Johny(1).pptx
 
Guideline for management of TBI by Dr.sagor
Guideline for management of TBI by Dr.sagorGuideline for management of TBI by Dr.sagor
Guideline for management of TBI by Dr.sagor
 
Acute Gasteoenteritis in Children and Adults.pptx
Acute Gasteoenteritis in Children and Adults.pptxAcute Gasteoenteritis in Children and Adults.pptx
Acute Gasteoenteritis in Children and Adults.pptx
 
nutrition.pptx
nutrition.pptxnutrition.pptx
nutrition.pptx
 
malaria guidelines - a case of tropical fever ppt.
malaria  guidelines - a case of tropical fever ppt.malaria  guidelines - a case of tropical fever ppt.
malaria guidelines - a case of tropical fever ppt.
 
Malaria
MalariaMalaria
Malaria
 
MALARIA
MALARIAMALARIA
MALARIA
 
Management of severe malaria
Management of severe malariaManagement of severe malaria
Management of severe malaria
 
Presentation TS neocone fluid and electrolyte dr hemant - Copy - Copy.pptx
Presentation TS neocone fluid and electrolyte dr hemant - Copy - Copy.pptxPresentation TS neocone fluid and electrolyte dr hemant - Copy - Copy.pptx
Presentation TS neocone fluid and electrolyte dr hemant - Copy - Copy.pptx
 
Isonized overdose
Isonized overdose Isonized overdose
Isonized overdose
 

More from MuniraMkamba

Chikungunya definition and it management
Chikungunya definition and it managementChikungunya definition and it management
Chikungunya definition and it management
MuniraMkamba
 
Meningitis , types and it's management both medical and nursing
Meningitis , types and it's management both medical and nursingMeningitis , types and it's management both medical and nursing
Meningitis , types and it's management both medical and nursing
MuniraMkamba
 
Hypertension and its management actual vs ideal
Hypertension and its management actual vs idealHypertension and its management actual vs ideal
Hypertension and its management actual vs ideal
MuniraMkamba
 
Hello syndrome slideshare and management
Hello syndrome slideshare and managementHello syndrome slideshare and management
Hello syndrome slideshare and management
MuniraMkamba
 
Hellp syndrome slideshare definition and management
Hellp syndrome slideshare  definition and managementHellp syndrome slideshare  definition and management
Hellp syndrome slideshare definition and management
MuniraMkamba
 
Management of tuberculosis
Management of tuberculosis Management of tuberculosis
Management of tuberculosis
MuniraMkamba
 
Nursing care plan
Nursing care planNursing care plan
Nursing care plan
MuniraMkamba
 
Jaundice in adults
Jaundice in adults Jaundice in adults
Jaundice in adults
MuniraMkamba
 
Stroke
Stroke Stroke
Stroke
MuniraMkamba
 
Physical examination
Physical examination Physical examination
Physical examination
MuniraMkamba
 
Nursing diagnosis for anaemia
Nursing diagnosis for anaemiaNursing diagnosis for anaemia
Nursing diagnosis for anaemia
MuniraMkamba
 
Nursing diagnosis by nanda
Nursing diagnosis by nandaNursing diagnosis by nanda
Nursing diagnosis by nanda
MuniraMkamba
 
GYNAECOLOGIC INFECTIONS 2016 (2).ppt
GYNAECOLOGIC INFECTIONS 2016 (2).pptGYNAECOLOGIC INFECTIONS 2016 (2).ppt
GYNAECOLOGIC INFECTIONS 2016 (2).ppt
MuniraMkamba
 
Minor disorders in pregnancy
Minor disorders in pregnancy Minor disorders in pregnancy
Minor disorders in pregnancy
MuniraMkamba
 
Hodgkin's and non Hodgkin's lymphoma
Hodgkin's and non Hodgkin's lymphoma Hodgkin's and non Hodgkin's lymphoma
Hodgkin's and non Hodgkin's lymphoma
MuniraMkamba
 
Disseminated intravascular coagulation
Disseminated intravascular coagulation Disseminated intravascular coagulation
Disseminated intravascular coagulation
MuniraMkamba
 
Thrombocytopenia purpura
Thrombocytopenia purpura Thrombocytopenia purpura
Thrombocytopenia purpura
MuniraMkamba
 
Polycythemia Vera
Polycythemia Vera Polycythemia Vera
Polycythemia Vera
MuniraMkamba
 
Multiple myeloma
Multiple myeloma Multiple myeloma
Multiple myeloma
MuniraMkamba
 
Multiple myeloma
Multiple myeloma Multiple myeloma
Multiple myeloma
MuniraMkamba
 

More from MuniraMkamba (20)

Chikungunya definition and it management
Chikungunya definition and it managementChikungunya definition and it management
Chikungunya definition and it management
 
Meningitis , types and it's management both medical and nursing
Meningitis , types and it's management both medical and nursingMeningitis , types and it's management both medical and nursing
Meningitis , types and it's management both medical and nursing
 
Hypertension and its management actual vs ideal
Hypertension and its management actual vs idealHypertension and its management actual vs ideal
Hypertension and its management actual vs ideal
 
Hello syndrome slideshare and management
Hello syndrome slideshare and managementHello syndrome slideshare and management
Hello syndrome slideshare and management
 
Hellp syndrome slideshare definition and management
Hellp syndrome slideshare  definition and managementHellp syndrome slideshare  definition and management
Hellp syndrome slideshare definition and management
 
Management of tuberculosis
Management of tuberculosis Management of tuberculosis
Management of tuberculosis
 
Nursing care plan
Nursing care planNursing care plan
Nursing care plan
 
Jaundice in adults
Jaundice in adults Jaundice in adults
Jaundice in adults
 
Stroke
Stroke Stroke
Stroke
 
Physical examination
Physical examination Physical examination
Physical examination
 
Nursing diagnosis for anaemia
Nursing diagnosis for anaemiaNursing diagnosis for anaemia
Nursing diagnosis for anaemia
 
Nursing diagnosis by nanda
Nursing diagnosis by nandaNursing diagnosis by nanda
Nursing diagnosis by nanda
 
GYNAECOLOGIC INFECTIONS 2016 (2).ppt
GYNAECOLOGIC INFECTIONS 2016 (2).pptGYNAECOLOGIC INFECTIONS 2016 (2).ppt
GYNAECOLOGIC INFECTIONS 2016 (2).ppt
 
Minor disorders in pregnancy
Minor disorders in pregnancy Minor disorders in pregnancy
Minor disorders in pregnancy
 
Hodgkin's and non Hodgkin's lymphoma
Hodgkin's and non Hodgkin's lymphoma Hodgkin's and non Hodgkin's lymphoma
Hodgkin's and non Hodgkin's lymphoma
 
Disseminated intravascular coagulation
Disseminated intravascular coagulation Disseminated intravascular coagulation
Disseminated intravascular coagulation
 
Thrombocytopenia purpura
Thrombocytopenia purpura Thrombocytopenia purpura
Thrombocytopenia purpura
 
Polycythemia Vera
Polycythemia Vera Polycythemia Vera
Polycythemia Vera
 
Multiple myeloma
Multiple myeloma Multiple myeloma
Multiple myeloma
 
Multiple myeloma
Multiple myeloma Multiple myeloma
Multiple myeloma
 

Recently uploaded

THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 

Recently uploaded (20)

THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 

Nsaids

  • 1. Division of National Malaria Programme – Komesha Malaria, Okoa Maisha Ministry of Health Module 2: Learning Unit 2 Management of Severe Malaria Training of Malaria Case Management Master trainers
  • 2. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Learning Unit 2: Management of Severe Malaria
  • 3. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Learning objectives By the end of the learning unit, the participants will be able to: 1. Identify signs and symptoms of Severe malaria 2. Diagnose Severe malaria 3. Describe pre-referral management of severe malaria 4. Describe management of severe malaria
  • 4. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Signs and symptoms of Severe Malaria Severe malaria is a life threatening condition defined as Peripheral parasitaemia in the presence of the following clinical or laboratory features • Prostration, • altered consciousness, • respiratory distress, • multiple generalized convulsions, • severe anaemia (Hb<5g/dl), • hypoglycaemia (<2.2mmol/l), • jaundice • NB- features may occur singly or in combination,
  • 5. National Malaria Control Programme – Komesha Malaria, Okoa Maisha What are the signs and symptoms of severe malaria (Brainstorm) GROUP BRAINSTORMING What are the signs & symptoms of severe malaria? 14
  • 6. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Conjugate deviation of the eyes to the left or upwards 6
  • 7. National Malaria Control Programme – Komesha Malaria, Okoa Maisha 7
  • 8. National Malaria Control Programme – Komesha Malaria, Okoa Maisha 8
  • 9. National Malaria Control Programme – Komesha Malaria, Okoa Maisha 9
  • 10. National Malaria Control Programme – Komesha Malaria, Okoa Maisha 10
  • 11. National Malaria Control Programme – Komesha Malaria, Okoa Maisha 11 11
  • 12. National Malaria Control Programme – Komesha Malaria, Okoa Maisha 12 12
  • 13. National Malaria Control Programme – Komesha Malaria, Okoa Maisha 13 13
  • 14. National Malaria Control Programme – Komesha Malaria, Okoa Maisha 14
  • 15. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Diagnosis of Severe malaria
  • 16. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Role of laboratory diagnosis in severe malaria • Parasitological confirmation is recommended • Presumptive treatment should be started immediately while waiting for parasitological confirmation • Antimalarial treatment should not be withheld if parasitological diagnosis is not possible or delayed • Other investigations to determine severity and prognosis should be undertaken where feasible • (HB, Blood sugar, Urea and electrolyte) • Positive slides do not rule out other causes of severe disease
  • 17. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Clinical Manifestations of Severe Malaria • Cerebral Malaria • Severe Anaemia • Hypoglycaemia
  • 18. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Assessment Tasks For Cerebral malaria (1) i. Clinical assessment • Assess level of consciousness using coma score. • Determine the presence of severe anaemia • Determine presence of respiratory distress
  • 19. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Assessment Tasks For Cerebral malaria cont’d • Determine hydration status • Assess for renal insufficiency • Assess for evidence of Disseminated Intravascular Coagulopathy (DIC) • Assess for stiff neck and do lumbar puncture
  • 20. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Assessment Tasks For Cerebral malaria cont’d ii. Laboratory Tests • In children with altered consciousness, start treatment for both malaria and meningitis until lumbar puncture results exclude meningitis • Do blood glucose to rule out hypoglycemia
  • 21. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Assessment Tasks For Severe Anaemia (1) i. Clinical assessment • Examine for pallor on the palms and conjunctiva • Determine presence of respiratory distress • Assess for shock • Assess for evidence of Disseminated Intravascular Coagulopathy • Assess for evidence of cardiac failure • Pulmonary oedema
  • 22. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Assessment Tasks For Severe Anaemia (2) ii. Laboratory test. • Determine haemoglobin levels, blood group and cross match where applicable
  • 23. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Assessment Tasks For Hypoglycaemia i Clinical assessment • Assess the level of consciousness ii Laboratory test • Determine the blood glucose level
  • 24. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Part 2 Pre-referral management
  • 25. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Pre-referral treatment (1) • Treatment for suspected severe malaria provided at the peripheral facility where IV infusion cannot be given as patient waits for referral • Initiate treatment with IM artesunate • If patient has altered consciousness, administer antibiotic for meningitis (e.g. Ceftriaxone) Pre-referral Treatment • Treatment for suspected severe malaria provided at the peripheral facility where IV infusion cannot be given as patient waits for referral • If patient has altered consciousness, administer antibiotic for meningitis (e.g. Ceftriaxone) • Initiate treatment with IM artesunate 44 Pre-referral Treatment cont’d Transport child lying on the side Health worker should accompany patient Investigate mode of transporting patient All attempts should be made to refer patients • Give clear referral note with clinical picture and medications given and doses • If investigations were done, send results or slides along with patient 45 ARTESUNATE PRODUCT DESCRIPTION • Artesunate dispensed as Artesunic powder • Dissolved in sodium bircarbonate (5%) to form sodium artesunate • Solution then dissolved in 5mls of normal saline or 5% dextrose • USE OF WATER FOR INJECTION NOT RECOMMEDED Artesunate powder Bicarbonate ampoule Saline Solution + 47
  • 26. National Malaria Control Programme – Komesha Malaria, Okoa Maisha • Administer treatment in the following order of preference depending on availability: IM artesunate Rectal Artesunate (suppositories) IM Quinine IM Artemether ARTESUNATE PRODUCT DESCRIPTION • Artesunate dispensed as Artesunic powder • Dissolved in sodium bircarbonate (5%) to form sodium artesunate • Solution then dissolved in 5mls of normal saline or 5% dextrose • USE OF WATER FOR INJECTION NOT RECOMMEDED Artesunate powder Bicarbonate ampoule Saline Solution + 47 Pre-Referral dosage of IM artesunate • Administer 3.0mg/kg for children < 20kg , then refer • Administer 2.4mg/kg for children > 20kg and adults, then refer 48
  • 27. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Rectal Artesunate • Rectal artesunate is presented as suppositories • Administer a single dose • If expelled before 30 mins, insert a second one • For young children hold the buttocks for 10 mins to retain the suppository • For patients above 6 yrs, Rectal artesunate is not recommended
  • 28. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Dose of IM quinine • Quinine must be diluted to a maximum of • 50mg/ml in children • 100mg/ml in adults before IM administration • Loading dose for IM quinine is 20mg/kg in ALL age groups ( to a maximum of 1200mg) • A maximum of 3ml to be injected at one site
  • 29. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Disadvantages of IM quinine • Risk of sterile abscesses • Relatively poor absorption of quinine (less drug available) compared to IV or oral quinine – the illness may worsen
  • 30. National Malaria Control Programme – Komesha Malaria, Okoa Maisha IM Artemether • IM artemether is fat soluble • It is provided in dilution form • Administer as a stat dose • Administer IM 3.2mg/kg/body wt • Refer patient after administration
  • 31. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Part 3 In patient management of severe malaria
  • 32. National Malaria Control Programme – Komesha Malaria, Okoa Maisha IM Artemether • IM artemether is fat soluble • It is provided in dilution form • Administer as a start dose • Administer IM 3.2mg/kg/body wt • Refer patient after administration STEP 1. WEIGH THE PATIENT STEP 2. CHECK VIALS NEEDED NOTE: • Each vial require separate reconstitution, dilution and administration • Reconstitute immediately before use 54
  • 33. National Malaria Control Programme – Komesha Malaria, Okoa Maisha STEP 3: RECONSTITUTE A B C D STEP 4: DILUTION C B A D VOLUME FOR DILUTION IV IM Bicarbonate Solution Volume 1ml 1ml Saline Solution 5ml 2ml Total Volume 6ml 3ml Artesunate 60mg solution concentration 10mg/ml 20mg/ml 55
  • 34. National Malaria Control Programme – Komesha Malaria, Okoa Maisha STEP 5. CALCULATE DOSE Less than 20 kg(IV) Less than 20kg (IM) More than 20 kg(IV) More than 20kg (IM) 56
  • 35. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Part 3 Inpatient management of Severe Malaria STEP 1. WEIGH THE PATIENT STEP 2. CHECK VIALS NEEDED NOTE: • Each vial require separate reconstitution, dilution and administration • Reconstitute immediately before use 54 STEP 3: RECONSTITUTE A B C D STEP 4: DILUTION C B A D VOLUME FOR DILUTION IV IM Bicarbonate Solution Volume 1ml 1ml Saline Solution 5ml 2ml Total Volume 6ml 3ml Artesunate 60mg solution concentration 10mg/ml 20mg/ml 55 STEP 5. CALCULATE DOSE Less than 20 kg(IV) Less than 20kg (IM) More than 20 kg(IV) More than 20kg (IM) 56 6. ADMINISTER • 3 parenteral doses over 24 hrs • Continue parenteral treatment (1 dose daily) until patient can take oral medication (Max 7 days) • Mandatory full 3-day course of ACT as soon as patient can take oral medication – 1st dose of ACT btwn 8 & 12 hrs after last injection • Evaluate patients progress continuously 7. DOSING SCHEDULE 57
  • 36. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Quinine administration in children • Loading dose of 20mg/kg in 15ml/kg of 5% dextrose or normal saline to run over 4 hours • Omit loading dose if any quinine has been given in the previous 24 hours • 8 hours from commencement of initial dose, give 10mg/kg quinine in 10ml/kg of 5% dextrose or normal saline to run over 4 hours • Repeat 10mg/kg infusion every 8 hours until the patient is able to sit up and take oral medication
  • 37. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Quinine administration in adults • Loading dose of 20mg/kg (maximum of 1200mg)in 5% dextrose or normal saline to run over 4 hours • Omit loading dose if any quinine has been given in the previous 24 hours • Maintain with 10mg/kg (maximum of 600mg) infusion 8 hourly until the patient is able to take oral medication
  • 38. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Follow on treatment after IV quinine • Once all patients are able to take oral medication: • Give a full course of artemether-lumefantrine OR • Continue oral quinine at 10mg/kg (max 600mg) 8 hourly for a total of 7 days of treatment
  • 39. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Supportive treatment • Hypoglycaemia – IV or oral glucose (10% glucose 5 ml/kg) • Convulsions • diazepam 0.3mg/kg IV or 0.5 mg/kg rectally • Phenytoin or phenobarbitone • Severe anaemia – transfuse • Fluid and electrolyte balance • Fever and nursing care
  • 40. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Frequent questions 1. Would you give Artesunate / IV Quinine to a child with severe malaria and Hb of 3g/dl? 2. Would you give fluid to a child with Hb of 3g/dl before giving a blood transfusion?
  • 41. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Answers 1. Yes, Artesunate or quinine must be given as soon as possible while waiting for blood transfusion. 2. Yes, children with severe malaria and severe anaemia can be given fluids while waiting for blood transfusion.
  • 42. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case studies
  • 43. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case study 1 • A 2-year-old girl from an area with stable malaria develops fever and soon has a brief convulsion. The family lives in a remote community away from the city. Initially the mother gave the child a teaspoonful of herbal concoction. Later, on the evening of the same day, the child's speech became less comprehensible and shortly afterwards she was no longer responding to any call. It took the mother 4 hours to get to the nearest hospital and the child remained unconscious until they got there. In addition to the loss of consciousness, she was found on examination to be severely pale with a temperature of 38.5°C. • What key information is provided in this history? • What signs of severe disease can you identify? • How should this child’s illness be classified • What urgent treatment would you give • List 4 important laboratory tests to be done. • What specific treatment would you give this child?
  • 44. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case history 2 • The place: a rural clinic in a hyper endemic P. falciparum area. Various antimalarial drugs are available, but intravenous infusions cannot be given. • A child aged 20 months became feverish two days ago and has vomited several times today. One hour ago the child had a convulsion, described by the mother as a repetitive twitching of the limbs and mouth, followed by unresponsiveness for a few minutes. The child is now febrile (39°C), conscious, and withdraws promptly from any painful stimulus. A thick blood film shows P. falciparum rings “860/200”WBC. The child repeatedly vomits any antimalarial drug given by mouth.
  • 45. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case study 2 cont’d • Does the child have cerebral malaria? Why? • What should you do about the convulsions? • What treatment will you give? State dose & route of administration. On the second day of treatment, the child was brought back to the clinic. There was little change; he was still febrile and the parasitaemia was similar to the previous day. • Does this suggest that the child has drug resistant malaria? The child went on to complete a full course of AL. By the 3rd day, he was well and aparasitaemic. At the end of 7 days a further blood test showed gametocytes. • What should be done about the gametocytes present in the blood after treatment?
  • 46. National Malaria Control Programme – Komesha Malaria, Okoa Maisha …Case study 3 cont’d i. What are the differential diagnoses? ii.Was the patient right to think he was immune to malaria? iii.The thick blood film shows P falciparum 3900/200 WBC and the thin blood film shows that 26% of the red cells are parasitized. What else would you look for in the thin blood film? iv.What else would you do to investigate the bleeding tendency? v.What treatment is needed for the bleeding?
  • 47. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case study 3 • 4. A four-year-old girl is brought to the outpatient department of your hospital by her mother, late in the evening. The child was well until yesterday morning (36 hours ago), when she began to have fever. Yesterday she took meals but seemed restless; today she has refused food, and only drank a little. The mother says the child had a “fit” this morning; she regained consciousness immediately. For the past few hours the child has been increasingly drowsy, and for the last hour has been unconscious. • On examination the child is well nourished, unconscious and not dehydrated. The axillary temperature is 40.2°C; pulse 120 beats/min, regular; blood pressure 90/70 mmHg. No neck stiffness. Some yellowish sticky fluid is seen filling the external part of the left ear. There was no rash.
  • 48. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case study 3 i. What essential laboratory tests will you perform to guide your management of the patient? ii. Why does the blood glucose test have priority in this case? iii.Should you wait for the blood glucose test if it will take more than 2 hours? iv.So what should you do? In this child, a stix test on finger-prick capillary blood revealed a glucose level of 1.0 mmol/L (18 mg/dl). 50% dextrose was given intravenously but the child remained unconscious. What does this suggest? • The child has P falciparum parasitaemia 465/200 WBCs with hypoglycaemia.
  • 49. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case study 3 cont’d v. Does this exclude a diagnosis of meningitis? vi. If stiff neck is absent is it necessary to do a lumbar puncture? vii. Does clear & colourless cerebrospinal fluid exclude meningitis? viii. what antimalarial drug will you give the patient? Give the dose and route. ix. If haemoglobin is 6.3.mg/dL. What will you do? x. At what point would you give a blood transfusion? xi. If blood transfusion is necessary, how would you give the blood?
  • 50. National Malaria Control Programme – Komesha Malaria, Okoa Maisha xii. What clinical observations would you maintain during management? xiii. What laboratory tests would you repeat, and frequency? xiv. What should be looked for after the child has recovered?
  • 51. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case study 5 • The place: A country where P. falciparum malaria is transmitted in forested areas but not in the main cities. • A woman aged 25 years is brought to the outpatient department of the central hospital in the capital. She is a local resident, the wife of a business executive, and is in the seventh month of her pregnancy. • The patient became ill five days ago, with chills, sweating and headache. An antibiotic was prescribed and her condition seemed to improve, but yesterday she developed rigors and persistent vomiting. A blood film at the local clinic revealed malaria parasites, and oral quinine (600 mg every 8 hours) was prescribed. She took two doses. • Today she has been referred to your hospital because of confusion. Examination reveals a semiconscious woman who is unable to talk. She withdraws her hand from a painful stimulus but cannot localize a stimulus applied to the sternum or forehead. There is no neck stiffness, jaundice, pallor or rash. Axillary temperature is 39°C, pulse 90 beats/min, blood pressure 110/70 mmHg. The uterine fundus is palpable (26 - 28 weeks) and the foetal heart can be heard.
  • 52. National Malaria Control Programme – Komesha Malaria, Okoa Maisha …Case history 5 i) What other questions would you ask the patient’s relatives? ii) What tests are urgently required? ii) If the blood glucose is 1.2 mmol/L, what treatment will you give? iii) If the blood film shows P falciparum 465/200 WBCs, and the cerebrospinal fluid is normal except for low glucose, what antimalarial drug would you administer and by what route? iv) Would you prefer an alternative to quinine because of the pregnancy? v) Would you give a loading dose of quinine? vi) What nursing procedures are important during this treatment?
  • 53. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Case history 5 cont’d i. What other questions would you ask the patient’s relatives? ii. What important tests should be done?. • a) • b). • c). • d). iii.If the blood glucose is 1.2 mmol/L, what treatment will you give? iv.If the blood film shows P. falciparum 465/200 WBCs, and the cerebrospinal fluid is normal except for low glucose, what antimalarial drug would you administer and by what route?
  • 54. National Malaria Control Programme – Komesha Malaria, Okoa Maisha v. Would you prefer an alternative to quinine because of the pregnancy? vi. Would you give a loading dose of quinine? vii. What nursing procedures are important during this treatment? After 6 hours, the patient becomes increasingly restless. The respiratory rate increased to 40/minute. The blood glucose level is normal. Under these conditions, what special observations would you make? • a) • b)
  • 55. National Malaria Control Programme – Komesha Malaria, Okoa Maisha Thank you 55
  • 56. Division of National Malaria Programme – Komesha Malaria, Okoa Maisha Malaria Free KENYA Elimination SMEOR Case Mgmt SBC Vector Control MIP Prog Mgmt 56

Editor's Notes

  1. Self introduction Purpose of the presentation.
  2. Opisthotonos. There is also posturing of the arms in various positions. These features indicate severe cerebral dysfunction.
  3. White conjunctiva: Anaemia
  4. Palmar Pallor: Anaemia
  5. All we do is to achieve a malaria – free Kenya. Invite brief Q&A.